'The Contract Vaccine Manufacturing Market Will Reach $0.62 Billion in 2015' Predicts New Visiongain Report

'The Contract Vaccine Manufacturing'The Contract Vaccine Manufacturing Market Will Reach $0.62 Billion in 2015' Predicts New Visiongain Report PR Newswire LONDON, October 9, 2013 What's the outlook for producing vaccines? Visiongain's updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your research and analyses. There's rising demand for those products and services. In particular, outsourced vaccine manufacturing will expand from 2013 to 2023, with growing revenues. Forecasts and other analyses to help you stay ahead in knowledge In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. Also, you see qualitative analysis (SWOT and STEP), business news, outlooks and developmental trends. You receive 70 tables, 46 charts and two research interviews. You discover industry dynamics and growth potentials - the following sections show what you find in our new report. Discover prospects for the world market and submarkets Along with revenue prediction for the overall world market, you see forecasts to 2023 for these five submarkets: • Paediatric vaccines • Influenza vaccines • Adult prophylactic vaccines • Therapeutic vaccines • Contract vaccine manufacturing.